Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression. [electronic resource]
Producer: 20050727Description: 163-74 p. digitalISSN:- 0885-6222
- Adrenergic beta-Antagonists -- administration & dosage
- Depressive Disorder, Major -- drug therapy
- Double-Blind Method
- Drug Therapy, Combination
- Humans
- Individuality
- Pindolol -- administration & dosage
- Randomized Controlled Trials as Topic
- Receptor, Serotonin, 5-HT1A -- drug effects
- Selective Serotonin Reuptake Inhibitors -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.